Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gidal

Showing results (131-140 of 274) with videos related to

Pageof 28
Sort By:
Epilepsy & Behavior : E&B|November 5, 2023
Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran populationAlexis Biehl, Maralena Taube, Robert J Kotloski, et al.
Epilepsy Research|June 23, 2000
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailabilityB E Gidal, L L Radulovic, S Kruger, et al.
Therapeutic Drug Monitoring|October 1, 1993
Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxideB E Gidal, G D Anderson, T L Seaton, et al.
Archives of Neurology|April 12, 2006
Protracted ictal confusion in elderly patientsRaj D Sheth, Joseph F Drazkowski, Joseph I Sirven, et al.
Epilepsia|November 23, 2007
Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsyBruce Hermann, Michael Seidenberg, Mark Sager, et al.
Epilepsy Research|June 19, 2017
Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transportersBarry E Gidal, Scott Mintzer, Matthias Schwab, et al.
Neurology|April 17, 2015
Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsyBarry E Gidal, Antonio Laurenza, Ziad Hussein, et al.
Clinical Pharmacokinetics|October 3, 2013
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designsFrancisco J Diaz, Michel J Berg, Ron Krebill, et al.
Neurological Research|September 24, 1999
Saturable transport of gabapentin at the blood-brain barrierM S Luer, C Hamani, M Dujovny, et al.
Epilepsia|February 18, 2020
Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteersR Edward Hogan, Barry E Gidal, Barry Koplowitz, et al.
Pageof 28

Showing results (131-140 of 274) with videos related to

Sort By:
Pageof 28
Epilepsy & Behavior : E&B|November 5, 2023
Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran populationAlexis Biehl, Maralena Taube, Robert J Kotloski, et al.
Epilepsy Research|June 23, 2000
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailabilityB E Gidal, L L Radulovic, S Kruger, et al.
Therapeutic Drug Monitoring|October 1, 1993
Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxideB E Gidal, G D Anderson, T L Seaton, et al.
Archives of Neurology|April 12, 2006
Protracted ictal confusion in elderly patientsRaj D Sheth, Joseph F Drazkowski, Joseph I Sirven, et al.
Epilepsia|November 23, 2007
Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsyBruce Hermann, Michael Seidenberg, Mark Sager, et al.
Epilepsy Research|June 19, 2017
Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transportersBarry E Gidal, Scott Mintzer, Matthias Schwab, et al.
Neurology|April 17, 2015
Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsyBarry E Gidal, Antonio Laurenza, Ziad Hussein, et al.
Clinical Pharmacokinetics|October 3, 2013
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designsFrancisco J Diaz, Michel J Berg, Ron Krebill, et al.
Neurological Research|September 24, 1999
Saturable transport of gabapentin at the blood-brain barrierM S Luer, C Hamani, M Dujovny, et al.
Epilepsia|February 18, 2020
Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteersR Edward Hogan, Barry E Gidal, Barry Koplowitz, et al.
Pageof 28